Clinical Trial Update: A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase I/II clinical trial evaluating golidocitinib in combination with pomalidomide for relapsed/refractory peripheral T-cell lymphoma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Golidocitinib (golidocitinib)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL) | Phase 1, Phase 2 | Status: RECRUITING